< Back to search
Filter
1
Active & Responsive

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

for
HLA-A*0201 Positive Cells Present, Clear Cell Sarcoma (CCS)
Location: New York NY, Los Angeles CA
Sponsor: Sarcoma Alliance for Research through Collaboration

Sex: All

Age: 18+

Code: NCT06942442

Phase2, Recruiting
New

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT04661137

Phase2, Recruiting
New

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Philadelphia PA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06948084

Phase2, Recruiting
New

A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Rochester MN
Sponsor: Vyriad, Inc.

Sex: All

Age: 18+

Code: NCT07802717

Phase1, Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

for
Non-Hodgkin Lymphoma, Multiple Myeloma, Histiocytic Neoplasms,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05093335

Early_phase1, Recruiting

Interested in new multiple myeloma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Elranatamab in R/R Multiple Myeloma

for
Refractory Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06138275

Phase2, Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase1, Recruiting

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

for
Recurrent Multiple Myeloma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06785415

Phase1, Phase2, Recruiting

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

for
Multiple Myeloma
Location: Miami FL, Irvine CA
Sponsor: Hoag Memorial Hospital Presbyterian

Sex: All

Age: 21+

Code: NCT04814615

Phase2, Recruiting

The Ambient Light Multiple Myeloma Study

for
Multiple Myeloma
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 21+

Code: NCT05737732

Recruiting

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

for
Multiple Myeloma
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18 - 60

Code: NCT00800059

Phase1, Phase2, Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma, Cancer
Location: Wilmington NC, Durham NC, Chapel Hill NC, Charlotte NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05145400

Phase2, Recruiting

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

for
Multiple Myeloma
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21+

Code: NCT04314752

Recruiting

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

for
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia,
Location: Nashville TN
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT04663100

Recruiting

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Greenville SC, Kettering OH, Yakima WA,
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01199718

Phase1, Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

for
Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms,
Location: Atlanta GA
Sponsor: OriCell Therapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06271252

Phase1, Recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

for
Refractory Multiple Myeloma
Location: Ottawa, Kingston, Hamilton, London, Vancouver
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: All

Age: 18+

Code: NCT06421675

Phase2, Recruiting

CAR T-cell Therapy in Patients With Renal Dysfunction

for
Non-hodgkin Lymphoma,B Cell, Multiple Myeloma,
Location: Atlanta GA
Sponsor: Northside Hospital, Inc.

Sex: All

Age: 18+

Code: NCT05909059

Phase2, Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Montreal, Deerfield Beach FL, Miami FL, Coral Gables FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06057402

Recruiting

Sleep Apnea in Patients With MGUS and MM

for
Multiple Myeloma,
Location: Iowa City IA
Sponsor: Michael Tomasson

Sex: All

Age: 18 - 70+

Code: NCT04114084

Recruiting